From N-of-1 therapy to health-system implementation
nature.com/articles/s4157…rdcu.be/czXCkzMfDeda
This Correspondence article highlights the need for transparent frameworks to prioritize the patients and targets for which n-of-1 therapies are developed
Soft drugs: design principles and topical applications
nature.com/articles/s4157…rdcu.be/kmQs1pcFN4ma
Soft drugs are rapidly inactivated after exerting their therapeutic effect, enabling potent local activity while minimizing systemic toxicity. Find out more in this new Review
The cellular landscape of druggable RNA-binding proteins
nature.com/articles/s4157…rdcu.be/Xdw8gA2w82Ea
This new Perspective by @TzelepisLab et al. discusses opportunities to therapeutically target RNA-binding proteins, which are involved in the development of multiple diseases